CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | propanal |
|
Accession: | CHEBI:17153
|
browse the term
|
Definition: | An aldehyde that consists of ethane bearing a formyl substituent. The parent of the class of propanals. |
Synonyms: | related_synonym: | 1-Propanal; Aldehyde propionique; C2H5CHO; Formula=C3H6O; InChI=1S/C3H6O/c1-2-3-4/h3H,2H2,1H3; InChIKey=NBBJYMSMWIIQGU-UHFFFAOYSA-N; Methylacetaldehyde; Propaldehyde; Propanaldehyde; Propional; Propionaldehyde; Propionic aldehyde; Propyl aldehyde; Propylaldehyde; Propylic aldehyde; SMILES=[H]C(=O)CC; n-Propanal; n-Propionaldehyde |
| alt_id: | CHEBI:14898; CHEBI:26281; CHEBI:41359; CHEBI:45052; CHEBI:8468 |
| xref: | CAS:123-38-6; HMDB:HMDB0003366; KEGG:C00479 |
| xref_mesh: | MESH:C005556 |
| xref: | MetaCyc:CPD-665; PDBeChem:CBG; PMID:20097366; PMID:21568340; Reaxys:506010; UM-BBD_compID:c0207; Wikipedia:Propanal |
|
|
|
G |
A1bg |
alpha-1-B glycoprotein |
increases expression |
ISO |
propionaldehyde results in increased expression of A1BG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:102,294,805...102,298,522
Ensembl chr 7:102,294,797...102,298,522
|
|
G |
A2m |
alpha-2-macroglobulin |
increases expression |
ISO |
propionaldehyde results in increased expression of A2M mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
|
|
G |
Aanat |
aralkylamine N-acetyltransferase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AANAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:105,568,091...105,572,407
Ensembl chr10:105,568,091...105,572,403
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
ISO |
propionaldehyde results in increased expression of AASS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of ABAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:7,093,406...7,200,439
Ensembl chr10:7,093,405...7,200,499
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
|
|
G |
Abca4 |
ATP binding cassette subfamily A member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:225,645,539...225,783,288
Ensembl chr 2:225,645,568...225,783,287
|
|
G |
Abcb5 |
ATP binding cassette subfamily B member 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCB5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:146,805,481...146,902,339
Ensembl chr 6:146,805,599...146,902,339
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCC6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:101,954,786...102,013,252
Ensembl chr 1:101,959,540...102,013,243
|
|
G |
Abcg4 |
ATP binding cassette subfamily G member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCG4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:48,604,915...48,626,219
Ensembl chr 8:48,606,403...48,619,592
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCG5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:7,935,771...7,961,207
Ensembl chr 6:7,935,771...7,961,207
|
|
G |
Abhd8 |
abhydrolase domain containing 8 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABHD8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:19,866,028...19,872,765
Ensembl chr16:19,866,022...19,872,774
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABLIM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:57,126,534...57,245,965
Ensembl chr18:57,128,399...57,245,666
|
|
G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ACMSD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:44,424,689...44,468,734
Ensembl chr13:44,424,689...44,468,734
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ACOT4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:107,517,668...107,522,952
Ensembl chr 6:107,517,668...107,522,952
|
|
G |
Acot9 |
acyl-CoA thioesterase 9 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of ACOT9 gene |
CTD |
PMID:30002397 |
|
NCBI chr X:43,543,069...43,592,200
Ensembl chr X:43,543,070...43,592,200
|
|
G |
Acrv1 |
acrosomal vesicle protein 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ACRV1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:39,164,991...39,170,568
Ensembl chr 8:39,164,916...39,170,736
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
increases expression |
ISO |
propionaldehyde results in increased expression of ACTA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:56,674,072...56,677,084
Ensembl chr19:56,674,074...56,677,084
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
ISO |
propionaldehyde results in increased expression of ACTA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ACVRL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:142,769,942...142,787,336
Ensembl chr 7:142,776,252...142,787,335
|
|
G |
Adam11 |
ADAM metallopeptidase domain 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:90,731,260...90,749,221
Ensembl chr10:90,731,148...90,749,217
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:31,146,107...31,240,582
Ensembl chr10:31,146,107...31,240,582
|
|
G |
Adam21 |
ADAM metallopeptidase domain 21 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:39,138,561...39,148,460
Ensembl chr16:39,144,972...39,147,702 Ensembl chr16:39,144,972...39,147,702
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAM33 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:123,595,018...123,607,549
Ensembl chr 3:123,595,560...123,607,352
|
|
G |
Adamts10 |
ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:18,409,147...18,439,012
Ensembl chr 7:18,409,147...18,439,012
|
|
G |
Adamts14 |
ADAM metallopeptidase with thrombospondin type 1 motif, 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:30,812,319...30,888,936
Ensembl chr20:30,812,353...30,888,751
|
|
G |
Adamts17 |
ADAM metallopeptidase with thrombospondin type 1 motif, 17 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:127,802,872...128,126,764
Ensembl chr 1:127,802,978...128,124,171
|
|
G |
Adamts19 |
ADAM metallopeptidase with thrombospondin type 1 motif, 19 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:53,915,807...54,099,856
Ensembl chr18:53,915,807...54,099,120
|
|
G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:89,622,996...89,632,485
Ensembl chr13:89,622,632...89,634,419
|
|
G |
Adamts6 |
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:34,374,142...34,589,676
Ensembl chr 2:34,374,158...34,586,755
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTSL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:144,238,958...144,561,065
Ensembl chr 1:144,239,020...144,561,247
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTSL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:197,803,572...197,815,058
Ensembl chr 2:197,803,584...197,814,808
|
|
G |
Adap2 |
ArfGAP with dual PH domains 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:67,494,851...67,527,582
Ensembl chr10:67,494,984...67,526,426
|
|
G |
Adgra2 |
adhesion G protein-coupled receptor A2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:69,094,587...69,133,015
Ensembl chr16:69,095,936...69,132,584
|
|
G |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:115,766,484...115,828,514
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:9,431,888...9,585,883
Ensembl chr 9:9,431,860...9,585,865
|
|
G |
Adgrf4 |
adhesion G protein-coupled receptor F4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:20,951,249...20,982,493
Ensembl chr 9:20,951,260...20,982,487
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRV1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:8,926,843...9,504,455
Ensembl chr 2:8,926,850...9,504,134
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADH1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADH6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:243,656,568...243,687,857
Ensembl chr 2:243,550,627...243,687,857
|
|
G |
Adora2a |
adenosine A2a receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of ADORA2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:277,537,585...277,538,985
Ensembl chr 1:277,537,585...277,538,985
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADRB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Adtrp |
androgen-dependent TFPI-regulating protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ADTRP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:22,619,913...22,688,296
Ensembl chr17:22,619,891...22,688,307
|
|
G |
Afap1l2 |
actin filament associated protein 1-like 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AFAP1L2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:277,730,760...277,827,299
Ensembl chr 1:277,730,760...277,827,269
|
|
G |
Aff2 |
AF4/FMR2 family, member 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AFF2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:153,539,951...154,051,022
Ensembl chr X:153,539,668...154,051,181
|
|
G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AGAP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:70,360,199...70,377,422
Ensembl chr 7:70,364,813...70,377,422
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
Agt |
angiotensinogen |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGTR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Ahnak2 |
AHNAK nucleoprotein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AHNAK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:137,335,273...137,380,219
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression |
ISO |
propionaldehyde results in increased expression of AHRR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:31,603,297...31,698,329
Ensembl chr 1:31,603,297...31,698,329
|
|
G |
Aif1l |
allograft inflammatory factor 1-like |
increases expression |
ISO |
propionaldehyde results in increased expression of AIF1L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:9,237,944...9,262,628
Ensembl chr 3:9,237,944...9,262,628
|
|
G |
Aire |
autoimmune regulator |
increases methylation |
ISO |
propionaldehyde results in increased methylation of AIRE gene |
CTD |
PMID:30002397 |
|
NCBI chr20:11,365,630...11,380,636
Ensembl chr20:11,365,697...11,380,631
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
affects reduction increases reduction |
ISO |
AKR1B1 protein affects the reduction of propionaldehyde analog AKR1B1 protein results in increased reduction of propionaldehyde |
CTD |
PMID:9890881 PMID:11306073 |
|
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AKR1C4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:69,441,253...69,460,334
Ensembl chr17:69,441,223...69,460,321
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases oxidation multiple interactions increases metabolic processing |
EXP ISO |
ALDH1A1 protein results in increased oxidation of propionaldehyde [ALDH1A1 protein binds to NAD] which results in increased oxidation of propionaldehyde; [ALDH1A1 protein co-treated with NAD] results in increased oxidation of propionaldehyde; [NAD co-treated with propionaldehyde] inhibits the reaction [Acrolein results in decreased activity of ALDH1A1 protein]; propionaldehyde inhibits the reaction [Acrolein results in decreased activity of ALDH1A1 protein] ALDH1A1 protein results in increased metabolism of propionaldehyde |
CTD |
PMID:10559215 PMID:10856427 PMID:10998257 PMID:21256123 PMID:21349255 PMID:22339434 PMID:25450233 |
|
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:127,302,920...127,337,828
Ensembl chr 1:127,301,128...127,337,882
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
multiple interactions |
ISO |
[ALDH1B1 protein co-treated with NAD] results in increased metabolism of propionaldehyde |
CTD |
PMID:7779080 |
|
NCBI chr 5:61,382,351...61,387,359
Ensembl chr 5:61,382,351...61,387,358
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ALDH1L1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:123,516,553...123,564,067
Ensembl chr 4:123,516,788...123,557,501
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects metabolic processing increases oxidation increases metabolic processing multiple interactions |
ISO |
ALDH2 protein polymorphism affects the metabolism of propionaldehyde ALDH2 protein results in increased oxidation of propionaldehyde ALDH2 protein results in increased metabolism of propionaldehyde daidzin inhibits the reaction [ALDH2 protein results in increased oxidation of propionaldehyde]; Magnesium promotes the reaction [ALDH2 protein results in increased oxidation of propionaldehyde]; molinate inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]; molinate metabolite inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]; molinate sulfoxide inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde] |
CTD |
PMID:11744614 PMID:20954713 PMID:21349255 PMID:23295226 |
|
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases metabolic processing |
ISO |
ALDH3A1 protein results in increased metabolism of propionaldehyde |
CTD |
PMID:19822198 PMID:21256123 |
|
NCBI chr10:47,490,168...47,499,855
Ensembl chr10:47,490,153...47,499,876
|
|
G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ALDH3B1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:219,145,457...219,181,536
Ensembl chr 1:219,145,459...219,186,860
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ALDH4A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:158,090,238...158,115,725
Ensembl chr 5:158,042,587...158,135,733
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
increases expression |
ISO |
propionaldehyde results in increased expression of ALOX5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ALOX5AP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:6,854,930...6,879,112
Ensembl chr12:6,854,920...6,879,154
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AMBP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:78,975,690...78,986,021
Ensembl chr 5:78,975,678...78,985,990
|
|
G |
Amhr2 |
anti-Mullerian hormone receptor type 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AMHR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:144,052,202...144,060,678
Ensembl chr 7:144,052,061...144,060,685
|
|
G |
Amotl1 |
angiomotin-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AMOTL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:13,037,265...13,157,701
Ensembl chr 8:13,042,641...13,109,487
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AMPD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:175,585,301...175,630,479
Ensembl chr 1:175,586,097...175,630,467
|
|
G |
Amph |
amphiphysin |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AMPH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:48,304,324...48,562,838
Ensembl chr17:48,304,322...48,562,905
|
|
G |
Angpt1 |
angiopoietin 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANGPT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
|
|
G |
Ankdd1a |
ankyrin repeat and death domain containing 1A |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKDD1A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:71,034,630...71,057,265
Ensembl chr 8:71,035,309...71,055,969
|
|
G |
Ankh |
ANKH inorganic pyrophosphate transport regulator |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANKH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:80,131,563...80,256,948
Ensembl chr 2:80,131,563...80,256,954
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:254,726,985...254,745,673
Ensembl chr 1:254,726,969...254,735,548
|
|
G |
Ankrd2 |
ankyrin repeat domain 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:261,281,859...261,291,307
Ensembl chr 1:261,281,543...261,291,394
|
|
G |
Ankrd29 |
ankyrin repeat domain 29 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD29 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:3,673,915...3,676,187
Ensembl chr18:3,673,915...3,676,188
|
|
G |
Ankrd34a |
ankyrin repeat domain 34A |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD34A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:198,720,277...198,725,155
Ensembl chr 2:198,721,724...198,725,154
|
|
G |
Ankrd34b |
ankyrin repeat domain 34B |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD34B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:22,000,106...22,016,764
Ensembl chr 2:22,000,106...22,016,030
|
|
G |
Ankrd55 |
ankyrin repeat domain 55 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD55 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:43,819,234...44,196,602
Ensembl chr 2:44,096,061...44,196,605
|
|
G |
Anks4b |
ankyrin repeat and sterile alpha motif domain containing 4B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANKS4B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:189,940,305...189,942,113
Ensembl chr 1:189,940,291...189,942,112
|
|
G |
Anln |
anillin, actin binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANLN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:23,336,455...23,397,122
Ensembl chr 8:23,337,621...23,390,773
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANP32B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:62,070,709...62,094,633
Ensembl chr 5:62,071,346...62,094,633
|
|
G |
Anp32e |
acidic nuclear phosphoprotein 32 family member E |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANP32E mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:198,040,573...198,057,005
Ensembl chr 2:198,040,536...198,057,003
|
|
G |
Antxr1 |
ANTXR cell adhesion molecule 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANTXR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:118,946,267...119,131,202
Ensembl chr 4:118,946,268...119,131,202
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANTXR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:13,191,716...13,331,286
Ensembl chr14:13,192,347...13,274,978
|
|
G |
Anxa10 |
annexin A10 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANXA10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:29,674,699...29,741,521
Ensembl chr16:29,674,793...29,741,465
|
|
G |
Anxa11 |
annexin A11 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANXA11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:3,867,193...3,912,043
Ensembl chr16:3,867,208...3,912,148
|
|
G |
Anxa13 |
annexin A13 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANXA13 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:98,217,642...98,270,442
Ensembl chr 7:98,217,642...98,270,110
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANXA6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:40,320,581...40,375,605
Ensembl chr10:40,320,581...40,375,605
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AOC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:89,251,370...89,259,313
Ensembl chr10:89,251,370...89,259,313
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AOX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:64,929,682...65,007,872
Ensembl chr 9:64,929,721...65,007,870
|
|
G |
Ap1m2 |
adaptor related protein complex 1 subunit mu 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AP1M2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:22,318,941...22,336,827
Ensembl chr 8:22,319,331...22,336,794
|
|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AP1S1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:22,665,128...22,676,079
Ensembl chr12:22,665,112...22,676,075
|
|
G |
Ap1s3 |
adaptor related protein complex 1 subunit sigma 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AP1S3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:85,386,752...85,445,977
Ensembl chr 9:85,387,065...85,445,939
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apobec3 |
apolipoprotein B mRNA editing enzyme catalytic subunit 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of APOBEC3H mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:121,108,108...121,128,346
Ensembl chr 7:121,109,241...121,128,542
|
|
G |
Apod |
apolipoprotein D |
increases expression |
ISO |
propionaldehyde results in increased expression of APOD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:72,705,204...72,726,263
Ensembl chr11:72,705,129...72,726,301
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
ISO |
propionaldehyde results in increased expression of APOE mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
Apoh |
apolipoprotein H |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:96,640,013...96,653,939
Ensembl chr10:96,639,924...96,653,938
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of APOLD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:168,752,142...168,755,024
Ensembl chr 4:168,752,133...168,755,023
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AQP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ARC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:115,907,097...115,911,059
Ensembl chr 7:115,907,097...115,910,541
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
propionaldehyde results in increased expression of AREG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:102,311,097...102,338,406
Ensembl chr 6:102,311,116...102,338,520
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARHGAP11A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:105,281,827...105,298,108
Ensembl chr 3:105,281,827...105,298,108
|
|
G |
Arhgap22 |
Rho GTPase activating protein 22 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGAP22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:9,454,269...9,613,508
Ensembl chr16:9,486,832...9,613,528
|
|
G |
Arhgap25 |
Rho GTPase activating protein 25 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGAP25 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,249,682...119,327,822
Ensembl chr 4:119,249,682...119,327,822
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGDIB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:170,913,920...170,932,789
Ensembl chr 4:170,913,923...170,932,618
|
|
G |
Arhgef4 |
Rho guanine nucleotide exchange factor 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGEF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:41,160,562...41,305,015
Ensembl chr 9:41,295,909...41,302,501
|
|
G |
Arl14 |
ADP-ribosylation factor like GTPase 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARL14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:165,835,196...165,836,291
Ensembl chr 2:165,835,701...165,836,279
|
|
G |
Arl4c |
ADP ribosylation factor like GTPase 4C |
increases expression |
ISO |
propionaldehyde results in increased expression of ARL4C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:95,783,651...95,787,092
Ensembl chr 9:95,786,508...95,787,094
|
|
G |
Armc3 |
armadillo repeat containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:85,895,841...86,009,403
Ensembl chr17:85,914,410...86,009,396
|
|
G |
Armh1 |
armadillo-like helical domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMH1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:136,073,056...136,112,344
Ensembl chr 5:136,073,056...136,112,344
|
|
G |
Armh4 |
armadillo-like helical domain containing 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:26,586,359...26,687,412
Ensembl chr15:26,587,179...26,678,420
|
|
G |
Arrb1 |
arrestin, beta 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:164,502,099...164,573,947
Ensembl chr 1:164,502,389...164,593,139
|
|
G |
Arsg |
arylsulfatase G |
increases expression |
ISO |
propionaldehyde results in increased expression of ARSG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:97,722,550...97,859,975
Ensembl chr10:97,771,264...97,863,311
|
|
G |
Arsi |
arylsulfatase family, member I |
increases expression |
ISO |
propionaldehyde results in increased expression of ARSI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:56,180,089...56,186,068
Ensembl chr18:56,180,089...56,186,068
|
|
G |
Art4 |
ADP-ribosyltransferase 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ART4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:170,830,851...170,841,187
Ensembl chr 4:170,830,851...170,841,187
|
|
G |
Arvcf |
ARVCF, delta catenin family member |
increases expression |
ISO |
propionaldehyde results in increased expression of ARVCF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:86,736,125...86,793,795
Ensembl chr11:86,736,142...86,793,791
|
|
G |
Arx |
aristaless related homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:62,363,757...62,376,139
Ensembl chr X:62,363,757...62,376,143
|
|
G |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASB18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:97,085,234...97,151,832
Ensembl chr 9:97,085,234...97,151,832
|
|
G |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:127,212,325...127,248,451
Ensembl chr 6:127,212,273...127,248,372
|
|
G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:30,461,673...30,501,340
Ensembl chr 4:30,313,102...30,501,329
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASF1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:25,077,918...25,092,491
Ensembl chr19:25,077,918...25,092,491
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASGR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:56,662,188...56,666,086
Ensembl chr10:56,662,242...56,666,086
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASGR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:56,710,446...56,723,608
Ensembl chr10:56,710,464...56,723,611
|
|
G |
Asmt |
acetylserotonin O-methyltransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of ASMT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:18,521,383...18,527,036
Ensembl chr12:18,521,401...18,526,250
|
|
G |
Asmtl |
acetylserotonin O-methyltransferase-like |
increases expression |
ISO |
propionaldehyde results in increased expression of ASMTL mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:18,532,090...18,534,761
Ensembl chr12:18,531,990...18,534,836
|
|
G |
Asphd2 |
aspartate beta-hydroxylase domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASPHD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:50,269,347...50,279,855
Ensembl chr12:50,269,347...50,279,745
|
|
G |
Aspm |
assembly factor for spindle microtubules |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASPM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:56,546,021...56,591,793
Ensembl chr13:56,546,021...56,591,793
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
|
|
G |
Astn2 |
astrotactin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASTN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:81,179,614...82,168,528
Ensembl chr 5:81,179,605...82,168,427
|
|
G |
Atcay |
ATCAY kinesin light chain interacting caytaxin |
increases expression |
ISO |
propionaldehyde results in increased expression of ATCAY mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:11,356,017...11,379,782
Ensembl chr 7:11,356,118...11,380,913
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP1A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:90,651,682...90,676,629
Ensembl chr13:90,651,686...90,676,629
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP1B2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:56,205,622...56,211,879
Ensembl chr10:56,205,625...56,211,891
|
|
G |
Atp2a3 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP2A3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:59,528,849...59,560,440
Ensembl chr10:59,529,785...59,560,433
|
|
G |
Atp4a |
ATPase H+/K+ transporting subunit alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP4A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:89,162,700...89,175,504
Ensembl chr 1:89,162,639...89,175,811
|
|
G |
Atp6v0a4 |
ATPase H+ transporting V0 subunit a4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP6V0A4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:65,736,585...65,821,916
Ensembl chr 4:65,736,585...65,818,521
|
|
G |
Atp8b3 |
ATPase phospholipid transporting 8B3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP8B3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:12,043,764...12,063,668
Ensembl chr 7:12,043,794...12,063,650
|
|
G |
Aurkb |
aurora kinase B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AURKB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:55,625,860...55,632,399
Ensembl chr10:55,626,741...55,634,991
|
|
G |
B3galt4 |
Beta-1,3-galactosyltransferase 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of B3GALT4 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr20:5,446,104...5,447,679
Ensembl chr20:5,446,104...5,447,673
|
|
G |
B3gnt6 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of B3GNT6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:163,143,027...163,149,496
Ensembl chr 1:163,143,917...163,148,948
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BAAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:64,768,397...64,777,368
Ensembl chr 5:64,768,401...64,777,368
|
|
G |
Baiap3 |
BAI1-associated protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BAIAP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:14,601,133...14,613,881
Ensembl chr10:14,599,197...14,613,878
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BARD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
|
|
G |
Barx1 |
BARX homeobox 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of BARX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:14,824,721...14,828,196
Ensembl chr17:14,824,734...14,828,329
|
|
G |
Batf2 |
basic leucine zipper ATF-like transcription factor 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BATF2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:221,538,006...221,546,650
Ensembl chr 1:221,538,104...221,545,782
|
|
G |
Batf3 |
basic leucine zipper ATF-like transcription factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BATF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:109,713,376...109,726,438
Ensembl chr13:109,713,489...109,724,863
|
|
G |
Bcl11a |
BAF chromatin remodeling complex subunit BCL11A |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL11A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:108,826,717...108,921,197
Ensembl chr14:108,826,831...108,921,669
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL2A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:96,551,424...96,559,527
Ensembl chr 8:96,551,245...96,559,483
|
|
G |
Bcl2l10 |
BCL2 like 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL2L10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:82,288,705...82,294,750
Ensembl chr 8:82,288,705...82,294,744
|
|
G |
Bco2 |
beta-carotene oxygenase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BCO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:54,965,577...54,990,604
Ensembl chr 8:54,965,583...54,998,864
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
ISO |
propionaldehyde results in increased expression of BDNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Bex2 |
brain expressed X-linked 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BEX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:106,556,838...106,558,366
Ensembl chr X:106,556,838...106,558,366
|
|
G |
Bex4 |
brain expressed, X-linked 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of BEX4 mRNA |
CTD |
PMID:26079696 |
|
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
increases expression |
ISO |
propionaldehyde results in increased expression of BHLHE41 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:180,230,742...180,235,138
Ensembl chr 4:180,232,382...180,234,804
|
|
G |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BICRA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:77,869,020...77,943,828
Ensembl chr 1:77,869,020...77,893,509
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
ISO |
propionaldehyde results in increased expression of BIK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:124,390,924...124,410,449
Ensembl chr 7:124,391,432...124,410,447
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BIRC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BIRC5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Blm |
BLM RecQ like helicase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BLM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:142,246,773...142,332,616
Ensembl chr 1:142,246,790...142,332,588
|
|
G |
Bmp10 |
bone morphogenetic protein 10 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of BMP10 gene |
CTD |
PMID:30002397 |
|
NCBI chr 4:119,224,906...119,230,534
Ensembl chr 4:119,225,040...119,230,728
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BMP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:26,955,142...27,112,820
Ensembl chr17:26,955,142...27,112,820
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of BMP7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:170,879,972...170,955,820
Ensembl chr 3:170,879,973...170,955,399
|
|
G |
Bmp8a |
bone morphogenetic protein 8a |
increases expression |
ISO |
propionaldehyde results in increased expression of BMP8A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:141,007,462...141,033,511
Ensembl chr 5:141,007,462...141,033,511
|
|
G |
Bmper |
BMP-binding endothelial regulator |
increases expression |
ISO |
propionaldehyde results in increased expression of BMPER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:24,369,916...24,615,484
Ensembl chr 8:24,369,916...24,615,479
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRCA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
|
|
G |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRIP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:73,507,009...73,632,742
Ensembl chr10:73,507,100...73,629,581
|
|
G |
Brpf3 |
bromodomain and PHD finger containing, 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRPF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:6,047,800...6,086,099
Ensembl chr20:6,049,286...6,086,099
|
|
G |
Btbd17 |
BTB domain containing 17 |
increases expression |
ISO |
propionaldehyde results in increased expression of BTBD17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:103,334,052...103,341,820
Ensembl chr10:103,334,052...103,340,922
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BTG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BUB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:120,373,604...120,404,910
Ensembl chr 3:120,373,604...120,404,910
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BUB1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:110,367,949...110,420,471
Ensembl chr 3:110,367,939...110,420,458
|
|
G |
C1qb |
complement C1q B chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:155,246,444...155,251,995
Ensembl chr 5:155,246,447...155,252,003
|
|
G |
C1ql4 |
complement C1q like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1QL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:140,766,517...140,771,415
Ensembl chr 7:140,767,737...140,770,647
|
|
G |
C1qtnf5 |
C1q and TNF related 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QTNF5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:48,443,515...48,445,639
Ensembl chr 8:48,443,767...48,445,637
|
|
G |
C1qtnf6 |
C1q and TNF related 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QTNF6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:119,746,150...119,752,727
Ensembl chr 7:119,746,118...119,753,290
|
|
G |
C1r |
complement C1r |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:157,126,060...157,136,825
Ensembl chr 4:157,125,998...157,136,829
|
|
G |
C1s |
complement C1s |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1S mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:157,143,592...157,155,592
Ensembl chr 4:157,143,592...157,155,609
|
|
G |
C2 |
complement C2 |
increases expression |
ISO |
propionaldehyde results in increased expression of C2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:4,542,340...4,561,152
Ensembl chr20:4,542,340...4,561,152
|
|
G |
C2H1orf54 |
chromosome 2 C1orf54 homolog |
increases expression |
ISO |
propionaldehyde results in increased expression of C1ORF54 mRNA |
CTD |
PMID:26079696 |
|
|
|
G |
C4bpa |
complement component 4 binding protein, alpha |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C4BPA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:47,342,090...47,377,580
Ensembl chr13:47,342,079...47,377,703
|
|
G |
C6 |
complement C6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:54,460,333...54,533,801
Ensembl chr 2:54,466,280...54,533,797
|
|
G |
C7H12orf80 |
chromosome 7 open reading frame, human C12orf80 |
increases expression |
ISO |
propionaldehyde results in increased expression of LINC02874 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:143,029,176...143,030,200
|
|
G |
Ca4 |
carbonic anhydrase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:72,272,286...72,281,069
Ensembl chr10:72,272,248...72,281,067
|
|
G |
Ca9 |
carbonic anhydrase 9 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CA9 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
|
|
G |
Cabp1 |
calcium binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CABP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:47,185,449...47,209,785
Ensembl chr12:47,179,664...47,209,784
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNA1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:1,740,026...1,924,959
Ensembl chr 3:1,740,024...1,924,827
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNA1G mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:82,129,071...82,197,828
Ensembl chr10:82,129,506...82,197,848
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNA1I mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:121,521,787...121,619,300
Ensembl chr 7:121,511,097...121,619,283
|
|
G |
Cacna2d2 |
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNA2D2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:116,154,661...116,285,643
Ensembl chr 8:116,154,736...116,284,985
|
|
G |
Cacng4 |
calcium voltage-gated channel auxiliary subunit gamma 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNG4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:95,954,160...96,015,484
Ensembl chr10:95,951,234...96,015,499
|
|
G |
Cacng7 |
calcium voltage-gated channel auxiliary subunit gamma 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNG7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:64,374,547...64,405,380
Ensembl chr 1:64,374,603...64,405,149
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CADM2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:4,175,078...4,397,335
Ensembl chr11:4,174,881...4,397,361
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of CALCA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
|
|
G |
Calhm3 |
calcium homeostasis modulator 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CALHM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:266,928,596...266,935,678
Ensembl chr 1:266,929,299...266,934,303
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CAMK2N1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:156,876,706...156,878,486
Ensembl chr 5:156,876,706...156,878,486
|
|
G |
Camkv |
CaM kinase-like vesicle-associated |
increases expression |
ISO |
propionaldehyde results in increased expression of CAMKV mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:116,715,755...116,730,061
Ensembl chr 8:116,715,755...116,730,061
|
|
G |
Camp |
cathelicidin antimicrobial peptide |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CAMP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:117,930,557...117,932,371
Ensembl chr 8:117,930,546...117,932,518
|
|
G |
Camta1 |
calmodulin binding transcription activator 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAMTA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:168,138,207...169,017,295
Ensembl chr 5:168,141,372...169,017,295
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
|
|
G |
Capn12 |
calpain 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPN12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:87,066,289...87,078,348
Ensembl chr 1:87,066,289...87,078,348
|
|
G |
Capn3 |
calpain 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:112,227,486...112,278,408
Ensembl chr 3:112,228,720...112,278,408
|
|
G |
Card9 |
caspase recruitment domain family, member 9 |
increases expression |
ISO |
propionaldehyde results in increased expression of CARD9 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:3,798,346...3,806,841
Ensembl chr 3:3,798,347...3,806,713
|
|
G |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CARMN mRNA |
CTD |
PMID:26079696 |
|
|
|
G |
Carns1 |
carnosine synthase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CARNS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:219,413,897...219,424,533
Ensembl chr 1:219,414,915...219,422,268
|
|
G |
Catsperz |
catsper channel auxiliary subunit zeta |
increases expression |
ISO |
propionaldehyde results in increased expression of CATSPERZ mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:222,179,451...222,182,716
Ensembl chr 1:222,179,436...222,182,721
|
|
G |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CC2D2B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:259,998,744...260,092,810
|
|
G |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCBE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:61,758,754...62,013,194
Ensembl chr18:61,759,289...61,788,863
|
|
G |
Ccdc103 |
coiled-coil domain containing 103 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC103 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:90,984,213...90,987,829
Ensembl chr10:90,984,227...90,987,823
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC113 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:9,912,124...9,932,183
Ensembl chr19:9,912,183...9,931,930
|
|
G |
Ccdc121 |
coiled-coil domain containing 121 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC121 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:99,819,380...99,821,055
Ensembl chr13:99,820,015...99,820,986
|
|
G |
Ccdc146 |
coiled-coil domain containing 146 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC146 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:10,269,798...10,421,724
Ensembl chr 4:10,295,122...10,421,415
|
|
G |
Ccdc148 |
coiled-coil domain containing 148 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC148 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:44,892,212...45,210,897
Ensembl chr 3:44,892,219...45,210,474
|
|
G |
Ccdc15 |
coiled-coil domain containing 15 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:39,759,077...39,830,235
Ensembl chr 8:39,762,035...39,830,306
|
|
G |
Ccdc153 |
coiled-coil domain containing 153 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC153 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:48,570,718...48,577,856
Ensembl chr 8:48,569,328...48,577,855
|
|
G |
Ccdc160 |
coiled-coil domain containing 160 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC160 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:140,168,880...140,177,402
Ensembl chr X:140,175,861...140,176,829
|
|
G |
Ccdc169 |
coiled-coil domain containing 169 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC169 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:144,551,382...144,581,044
Ensembl chr 2:144,551,390...144,581,044
|
|
G |
Ccdc18 |
coiled-coil domain containing 18 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:1,664,620...1,701,269 NCBI chr14:2,510,184...2,612,070
Ensembl chr14:2,509,363...2,610,929
|
|
G |
Ccdc28b |
coiled coil domain containing 28B |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC28B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:147,823,446...147,828,449
Ensembl chr 5:147,823,447...147,828,449
|
|
G |
Ccdc3 |
coiled-coil domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:76,991,722...77,093,515
Ensembl chr17:76,995,043...77,093,308
|
|
G |
Ccdc30 |
coiled-coil domain containing 30 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC30 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:138,364,211...138,462,922
Ensembl chr 5:138,364,167...138,462,864
|
|
G |
Cck |
cholecystokinin |
increases expression |
ISO |
propionaldehyde results in increased expression of CCK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:130,120,525...130,127,515
Ensembl chr 8:130,120,523...130,127,392
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
|
|
G |
Ccl21 |
C-C motif chemokine ligand 21 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCL21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:58,197,678...58,198,782
Ensembl chr 5:58,197,680...58,198,782
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL26 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:24,157,182...24,161,870
Ensembl chr12:24,158,766...24,161,869
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
|
|
G |
Ccm2l |
CCM2 like scaffold protein |
increases expression |
ISO |
propionaldehyde results in increased expression of CCM2L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:148,541,404...148,557,464
Ensembl chr 3:148,541,909...148,556,744
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:94,375,134...94,382,154
Ensembl chr 7:94,375,020...94,383,024
|
|
G |
Ccn5 |
cellular communication network factor 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCN5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:160,207,969...160,219,316
Ensembl chr 3:160,207,913...160,219,331
|
|
G |
Ccna1 |
cyclin A1 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CCNA1 gene |
CTD |
PMID:30002397 |
|
NCBI chr 2:144,456,689...144,503,570
Ensembl chr 2:144,458,153...144,467,912
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:30,782,133...30,791,106
Ensembl chr 2:30,783,915...30,791,221
|
|
G |
Ccnb1ip1 |
cyclin B1 interacting protein 1 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CCNB1IP1 gene |
CTD |
PMID:30002397 |
|
NCBI chr15:27,720,220...27,736,528
Ensembl chr15:27,720,223...27,733,785
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:76,847,972...76,861,165
|
|
G |
Ccnd2 |
cyclin D2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCND2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNE2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:24,434,077...24,446,406
Ensembl chr 5:24,434,872...24,446,406
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:13,594,687...13,619,935
Ensembl chr10:13,594,687...13,619,935
|
|
G |
Cd22 |
CD22 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:89,313,475...89,329,902
Ensembl chr 1:89,314,558...89,329,418
|
|
G |
Cd33 |
CD33 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD33 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:98,388,811...98,403,539
Ensembl chr 1:98,398,660...98,402,968
|
|
G |
Cd40 |
CD40 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD40 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cd47 |
Cd47 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD47 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:53,511,485...53,575,754
Ensembl chr11:53,514,595...53,575,175
|
|
G |
Cd52 |
CD52 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD52 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:152,322,910...152,324,469
Ensembl chr 5:152,322,916...152,324,469
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
increases expression |
ISO |
propionaldehyde results in increased expression of CD55 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292
|
|
G |
Cd68 |
Cd68 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD68 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
|
|
G |
Cd70 |
Cd70 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD70 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:9,842,585...9,845,728
Ensembl chr 9:9,842,585...9,845,728
|
|
G |
Cd79b |
CD79b molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD79B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:94,497,445...94,500,591
Ensembl chr10:94,497,448...94,500,591
|
|
G |
Cd82 |
Cd82 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD82 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:82,324,344...82,368,846
Ensembl chr 3:82,324,354...82,368,357
|
|
G |
Cd83 |
CD83 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD83 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:24,416,651...24,435,790
Ensembl chr17:24,416,651...24,435,790
|
|
G |
Cd8a |
CD8a molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD8A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:99,217,640...99,243,352
Ensembl chr 4:99,239,115...99,243,351
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:137,260,728...137,264,931
Ensembl chr 5:137,260,739...137,265,015
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC25C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:27,528,768...27,550,316
Ensembl chr18:27,528,354...27,550,224
|
|
G |
Cdc42bpg |
CDC42 binding protein kinase gamma |
increases expression |
ISO |
propionaldehyde results in increased expression of CDC42BPG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:221,673,334...221,693,518
Ensembl chr 1:221,673,590...221,693,518
|
|
G |
Cdc45 |
cell division cycle 45 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC45 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:86,328,785...86,354,099
Ensembl chr11:86,329,012...86,358,453
|
|
G |
Cdca3 |
cell division cycle associated 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:157,347,876...157,351,889
Ensembl chr 4:157,348,020...157,351,604
|
|
G |
Cdca5 |
cell division cycle associated 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:221,448,661...221,462,235
Ensembl chr 1:221,448,661...221,462,233
|
|
G |
Cdca8 |
cell division cycle associated 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:142,911,310...142,933,536
Ensembl chr 5:142,911,305...142,933,526
|
|
G |
Cdcp1 |
CUB domain containing protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDCP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:132,260,007...132,296,661
Ensembl chr 8:132,260,029...132,296,661
|
|
G |
Cdh15 |
cadherin 15 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDH15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:55,669,661...55,689,986
Ensembl chr19:55,669,626...55,689,992
|
|
G |
Cdh16 |
cadherin 16 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDH16 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:568,329...578,513
Ensembl chr19:568,287...578,520
|
|
G |
Cdh23 |
cadherin-related 23 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDH23 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:29,857,018...30,263,758
Ensembl chr20:29,857,637...29,990,111
|
|
G |
Cdip1 |
cell death-inducing p53 target 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDIP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:10,966,819...10,989,937
Ensembl chr10:10,967,658...10,989,936
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:56,024,903...56,032,610
Ensembl chr19:56,024,903...56,032,605
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDKN2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:129,347,731...129,352,886
Ensembl chr 5:129,347,732...129,352,886
|
|
G |
Cdnf |
cerebral dopamine neurotrophic factor |
increases expression |
ISO |
propionaldehyde results in increased expression of CDNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:78,721,230...78,735,324
Ensembl chr17:78,719,111...78,735,324
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:55,381,565...55,386,511
Ensembl chr19:55,381,565...55,386,511
|
|
G |
Cdyl2 |
chromodomain Y-like 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDYL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:49,087,131...49,222,528
Ensembl chr19:49,093,355...49,198,073
|
|
G |
Cecr2 |
CECR2, histone acetyl-lysine reader |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CECR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:153,217,521...153,327,153
Ensembl chr 4:153,217,782...153,322,564
|
|
G |
Celf4 |
CUGBP, Elav-like family member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CELF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:17,689,090...18,079,835
Ensembl chr18:17,698,038...17,716,880
|
|
G |
Celf5 |
CUGBP, Elav-like family member 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CELF5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:11,095,449...11,119,941
Ensembl chr 7:11,095,468...11,119,941
|
|
G |
Cemip |
cell migration inducing hyaluronidase |
increases expression |
ISO |
propionaldehyde results in increased expression of CEMIP mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 1:146,069,774...146,226,320
Ensembl chr 1:146,069,771...146,226,462
|
|
G |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CEND1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:214,407,072...214,410,069
Ensembl chr 1:214,408,100...214,408,549
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:27,072,259...27,080,863
Ensembl chr 6:27,072,166...27,080,856
|
|
G |
Cenpe |
centromere protein E |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPE mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:240,395,974...240,454,785
Ensembl chr 2:240,396,152...240,454,747
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:108,132,499...108,178,609
Ensembl chr13:108,132,499...108,178,609
|
|
G |
Cenph |
centromere protein H |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:30,766,637...30,780,123
Ensembl chr 2:30,766,590...30,780,121
|
|
G |
Cenpi |
centromere protein I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:105,147,045...105,198,798
Ensembl chr X:105,147,153...105,198,797
|
|
G |
Cenpj |
centromere protein J |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPJ mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:36,745,672...36,809,228
Ensembl chr15:36,746,088...36,798,814
|
|
G |
Cenpk |
centromere protein K |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:34,312,766...34,373,945
Ensembl chr 2:34,312,766...34,335,776
|
|
G |
Cenpn |
centromere protein N |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:49,457,461...49,479,989
Ensembl chr19:49,340,184...49,479,996
|
|
G |
Cenpo |
centromere protein O |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:28,648,804...28,663,527
Ensembl chr 6:28,649,638...28,663,233
|
|
G |
Cenpp |
centromere protein P |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:15,429,526...15,603,197
Ensembl chr17:15,429,708...15,603,199
|
|
G |
Cep78 |
centrosomal protein 78 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CEP78 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:233,185,815...233,214,876
Ensembl chr 1:233,186,989...233,214,758
|
|
G |
Cep85 |
centrosomal protein 85 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CEP85 gene |
CTD |
PMID:30002397 |
|
NCBI chr 5:152,359,693...152,406,530
Ensembl chr 5:152,359,700...152,406,518
|
|
G |
Cers1 |
ceramide synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CERS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:20,845,580...20,860,789
Ensembl chr16:20,845,576...20,860,789
|
|
G |
Cfap251 |
cilia and flagella associated protein 251 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP251 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:38,708,915...38,781,598
Ensembl chr12:38,709,595...38,782,010
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP300 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:6,218,391...6,236,438
Ensembl chr 8:6,218,393...6,235,967
|
|
G |
Cfap43 |
cilia and flagella associated protein 43 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP43 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:267,511,359...267,598,642
Ensembl chr 1:267,511,523...267,598,639
|
|
G |
Cfap52 |
cilia and flagella associated protein 52 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP52 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:54,470,834...54,512,157
Ensembl chr10:54,470,835...54,512,169
|
|
G |
Cfap58 |
cilia and flagella associated protein 58 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP58 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:271,292,320...271,400,675
Ensembl chr 1:271,292,390...271,400,597
|
|
G |
Cfap70 |
cilia and flagella associated protein 70 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP70 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:4,285,049...4,350,707
Ensembl chr15:4,285,052...4,350,714
|
|
G |
Cfap74 |
cilia and flagella associated protein 74 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFAP74 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:172,817,221...172,884,996
Ensembl chr 5:172,825,072...172,858,053
|
|
G |
Cfap92 |
cilia and flagella associated protein 92 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP92 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,572,669...119,626,852
|
|
G |
Cfb |
complement factor B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:4,536,206...4,542,073
Ensembl chr20:4,536,203...4,561,066 Ensembl chr20:4,536,203...4,561,066
|
|
G |
Cfi |
complement factor I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:235,264,149...235,305,779
Ensembl chr 2:235,264,219...235,305,781
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
increases expression |
ISO |
propionaldehyde results in increased expression of CGA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:50,362,491...50,393,368
Ensembl chr 5:50,381,244...50,393,367
|
|
G |
Cgn |
cingulin |
increases expression |
ISO |
propionaldehyde results in increased expression of CGN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:195,909,691...195,937,130
Ensembl chr 2:195,909,626...195,935,878
|
|
G |
Cgnl1 |
cingulin-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CGNL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:78,126,670...78,278,490
Ensembl chr 8:78,126,675...78,233,430
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:111,160,205...111,163,425
Ensembl chr 3:111,160,205...111,163,425
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHCHD10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:13,665,046...13,666,845
Ensembl chr20:13,665,031...13,667,333
|
|
G |
Chd3 |
chromodomain helicase DNA binding protein 3 |
decreases expression increases methylation |
ISO |
propionaldehyde results in decreased expression of CHD3 mRNA propionaldehyde results in increased methylation of CHD3 gene |
CTD |
PMID:26079696 PMID:30002397 |
|
NCBI chr10:55,943,467...55,970,417
Ensembl chr10:55,943,446...55,965,216
|
|
G |
Chd5 |
chromodomain helicase DNA binding protein 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHD5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:169,519,212...169,572,059
Ensembl chr 5:169,519,212...169,567,107
|
|
G |
Chit1 |
chitinase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHIT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:50,947,020...50,994,644
Ensembl chr13:50,974,872...50,994,643
|
|
G |
Chrac1 |
chromatin accessibility complex subunit 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:114,323,542...114,326,930
Ensembl chr 7:114,323,542...114,326,930
|
|
G |
Chrdl2 |
chordin-like 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRDL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:165,008,997...165,036,431
Ensembl chr 1:165,008,912...165,036,435
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:63,990,599...64,463,222
Ensembl chr17:63,990,599...63,994,169
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRNA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:59,594,007...59,607,122
Ensembl chr 8:59,592,403...59,607,275
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRNA7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:123,897,341...124,039,263
Ensembl chr 1:123,899,657...124,039,196
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRNB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:59,610,489...59,629,073
Ensembl chr 8:59,609,693...59,629,133
|
|
G |
Chst1 |
carbohydrate sulfotransferase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:81,441,785...81,512,829
Ensembl chr 3:81,498,022...81,512,807
|
|
G |
Chst11 |
carbohydrate sulfotransferase 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:26,641,856...26,890,503
Ensembl chr 7:26,645,422...26,859,716
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:103,186,759...103,190,612
Ensembl chr 8:103,188,651...103,190,243
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:44,115,065...44,136,092
Ensembl chr19:44,115,120...44,135,387
|
|
G |
Cib4 |
calcium and integrin binding family member 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:27,241,804...27,303,617
Ensembl chr 6:27,241,919...27,303,615
|
|
G |
Cibar2 |
CBY1 interacting BAR domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CIBAR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:53,740,763...53,754,738
Ensembl chr19:53,743,383...53,754,602
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIDEB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:34,439,844...34,444,244
Ensembl chr15:34,439,876...34,444,244
|
|
G |
Cip2a |
cellular inhibitor of PP2A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIP2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:54,373,794...54,404,704
Ensembl chr11:54,377,374...54,404,612
|
|
G |
Cit |
citron rho-interacting serine/threonine kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:46,334,669...46,494,152
Ensembl chr12:46,334,665...46,494,174
|
|
G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CITED1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:72,128,996...72,133,692
Ensembl chr X:72,128,994...72,133,692
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CITED4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:139,597,731...139,598,622
Ensembl chr 5:139,597,731...139,598,622
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CKAP2L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:121,796,221...121,822,352
Ensembl chr 3:121,796,238...121,822,436
|
|
G |
Ckb |
creatine kinase B |
increases expression |
ISO |
propionaldehyde results in increased expression of CKB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:136,142,956...136,145,838
Ensembl chr 6:136,142,956...136,145,837
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CKS1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:188,740,564...188,745,144
Ensembl chr 2:188,740,573...188,745,144
|
|
G |
Clcn4 |
chloride voltage-gated channel 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLCN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:25,016,177...25,082,563
Ensembl chr X:25,016,401...25,080,410
|
|
G |
Cldn22 |
claudin 22 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CLDN22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:47,534,349...47,535,358
Ensembl chr16:47,534,349...47,535,358
|
|
G |
Cldn3 |
claudin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLDN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:21,831,341...21,832,813
Ensembl chr12:21,831,342...21,832,813
|
|
G |
Cldn4 |
claudin 4 |
increases expression decreases expression |
ISO |
propionaldehyde results in increased expression of CLDN4 mRNA propionaldehyde results in decreased expression of CLDN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:24,761,210...24,763,008
Ensembl chr12:24,761,210...24,763,005
|
|
G |
Clic3 |
chloride intracellular channel 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLIC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:2,675,732...2,678,248
Ensembl chr 3:2,676,296...2,680,565
|
|
G |
Clmp |
CXADR-like membrane protein |
increases expression |
ISO |
propionaldehyde results in increased expression of CLMP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:44,846,685...44,975,460
Ensembl chr 8:44,847,157...44,975,457
|
|
G |
Clrn3 |
clarin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CLRN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:207,750,627...207,766,250
Ensembl chr 1:207,750,223...207,811,008
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
increases expression |
ISO |
propionaldehyde results in increased expression of CLTRN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:32,118,082...32,153,687
Ensembl chr X:32,118,054...32,153,794
|
|
G |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNIH2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:220,474,485...220,480,723
Ensembl chr 1:220,474,493...220,480,132
|
|
G |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNIH3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:99,663,150...99,770,625
Ensembl chr13:99,663,150...99,770,625
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:23,113,083...23,121,748
Ensembl chr 8:23,113,048...23,121,761
|
|
G |
Cnn2 |
calponin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:12,782,459...12,787,977
Ensembl chr 7:12,782,491...12,787,750
|
|
G |
Cobl |
cordon-bleu WH2 repeat protein |
increases expression |
ISO |
propionaldehyde results in increased expression of COBL mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:92,341,949...92,497,169
Ensembl chr14:92,342,957...92,577,936
|
|
G |
Col13a1 |
collagen type XIII alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL13A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:31,456,502...31,598,360
Ensembl chr20:31,456,852...31,598,118
|
|
G |
Col16a1 |
collagen type XVI alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL16A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:148,257,030...148,311,645
Ensembl chr 5:148,257,642...148,311,645
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL1A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Col26a1 |
collagen type XXVI alpha 1 chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of COL26A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:22,834,866...22,980,603
Ensembl chr12:22,835,019...22,980,603
|
|
G |
Col28a1 |
collagen type XXVIII alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL28A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:34,048,074...34,198,558
Ensembl chr 4:34,048,533...34,194,764
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL5A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL6A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:12,773,472...12,801,179
Ensembl chr20:12,773,427...12,801,180
|
|
G |
Colca2 |
colorectal cancer associated 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of COLCA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:55,674,561...55,682,811
Ensembl chr 8:55,674,840...55,681,930
|
|
G |
Colec12 |
collectin sub-family member 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of COLEC12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:867,048...1,054,047
Ensembl chr18:867,048...1,052,606
|
|
G |
Coro6 |
coronin 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of CORO6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:62,691,952...62,700,658
Ensembl chr10:62,691,953...62,699,723
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of COTL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:52,465,074...52,499,433
Ensembl chr19:52,465,087...52,499,433
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of COX17 gene |
CTD |
PMID:30002397 |
|
NCBI chr11:64,962,663...64,968,437
Ensembl chr11:64,962,666...64,968,437
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of COX6A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:199,624,037...199,626,255
Ensembl chr 1:199,624,037...199,624,783
|
|
G |
Cox8c |
cytochrome c oxidase subunit 8C |
increases expression |
ISO |
propionaldehyde results in increased expression of COX8C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:126,766,967...126,768,290
Ensembl chr 6:126,766,967...126,768,290
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Cpa4 |
carboxypeptidase A4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CPA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:57,883,849...57,907,826
Ensembl chr 4:57,883,849...57,907,826
|
|
G |
Cplx2 |
complexin 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPLX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:10,756,871...10,828,811
Ensembl chr17:10,756,285...10,818,835
|
|
G |
Cpn1 |
carboxypeptidase N subunit 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:263,733,887...263,762,758
Ensembl chr 1:263,733,519...263,762,785
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
ISO |
propionaldehyde results in decreased expression of PGCP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:71,709,174...72,167,413
Ensembl chr 7:71,709,157...72,167,417
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
increases expression |
ISO |
propionaldehyde results in increased expression of CPT1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:100,955,094...100,970,579
Ensembl chr 1:100,955,095...100,969,560
|
|
G |
Cpxm2 |
carboxypeptidase X (M14 family), member 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPXM2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:204,048,785...204,161,090
Ensembl chr 1:204,048,785...204,087,001
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRABP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:59,344,097...59,352,135
Ensembl chr 8:59,344,083...59,352,132
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRABP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:187,322,416...187,326,794
Ensembl chr 2:184,882,969...184,883,505
|
|
G |
Crb1 |
crumbs cell polarity complex component 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:56,270,519...56,462,893
Ensembl chr13:56,270,781...56,462,834
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CREB3L3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:11,490,852...11,499,287
Ensembl chr 7:11,490,852...11,499,282
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CREBBP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CRHR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:92,191,473...92,233,662
Ensembl chr10:92,191,718...92,232,645
|
|
G |
Crip2 |
cysteine-rich protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRIP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:137,953,545...137,958,491
Ensembl chr 6:137,953,545...137,958,490
|
|
G |
Crip3 |
cysteine-rich protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRIP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:16,931,862...16,934,714
Ensembl chr 9:16,931,862...16,934,714
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRLF1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:20,675,042...20,686,365
Ensembl chr16:20,675,042...20,686,317
|
|
G |
Crtac1 |
cartilage acidic protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRTAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:261,527,009...261,669,614
Ensembl chr 1:261,514,141...261,669,586
|
|
G |
Crx |
cone-rod homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CRX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:77,744,593...77,758,913
Ensembl chr 1:77,745,288...77,750,960
|
|
G |
Crybg1 |
crystallin beta-gamma domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYBG1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:48,927,942...49,123,724
Ensembl chr20:48,927,914...48,969,499
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYBG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:152,289,492...152,321,539
Ensembl chr 5:152,290,084...152,321,541
|
|
G |
Crym |
crystallin, mu |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:189,944,895...189,960,069
Ensembl chr 1:189,944,895...189,960,073
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF1R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
|
|
G |
Csf2ra |
colony stimulating factor 2 receptor subunit alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF2RA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:1,462,292...1,467,264
Ensembl chr14:1,462,358...1,467,264
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CSRP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:52,553,843...52,575,054
Ensembl chr13:52,553,775...52,575,051
|
|
G |
Csta |
cystatin A |
increases expression |
ISO |
propionaldehyde results in increased expression of CSTA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:67,555,792...67,566,980
Ensembl chr11:67,555,658...67,566,972
|
|
G |
Ctdsp1 |
CTD small phosphatase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CTDSP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:81,672,613...81,677,979
Ensembl chr 9:81,672,758...81,677,979
|
|
G |
Cthrc1 |
collagen triple helix repeat containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CTHRC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:77,966,722...77,977,004
Ensembl chr 7:77,966,722...77,977,004
|
|
G |
Ctnnd2 |
catenin delta 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CTNND2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:83,227,247...84,094,315
Ensembl chr 2:83,393,282...84,094,315
|
|
G |
Ctps1 |
CTP synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CTPS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:139,475,934...139,505,065
Ensembl chr 5:139,475,934...139,505,065
|
|
G |
Ctsh |
cathepsin H |
increases expression |
ISO |
propionaldehyde results in increased expression of CTSH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:97,439,155...97,458,293
Ensembl chr 8:97,439,161...97,458,287
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CXCL12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:9,109,731...9,117,754
Ensembl chr17:9,109,731...9,117,750
|
|
G |
Cxcl17 |
C-X-C motif chemokine ligand 17 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:82,267,381...82,279,145
Ensembl chr 1:82,267,381...82,279,145
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCR4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
|
|
G |
Cyb561 |
cytochrome b-561 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB561 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:94,136,993...94,147,567
Ensembl chr10:94,136,993...94,147,621
|
|
G |
Cyb5r1 |
cytochrome b5 reductase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB5R1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:51,229,697...51,236,447
Ensembl chr13:51,229,890...51,236,463
|
|
G |
Cyb5r2 |
cytochrome b5 reductase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB5R2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:171,971,424...171,981,586
Ensembl chr 1:171,971,701...171,979,933
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYFIP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:31,278,746...31,419,235
Ensembl chr10:31,278,746...31,419,235
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP1A1 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP26A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
|
|
G |
Cyp2c24 |
cytochrome P450, family 2, subfamily c, polypeptide 24 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP2C18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:258,074,797...258,139,176
Ensembl chr 1:258,074,860...258,139,176
|
|
G |
Cyp2g1 |
cytochrome P450, family 2, subfamily g, polypeptide 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CYP2G1P mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:83,626,639...83,638,154
Ensembl chr 1:83,626,639...83,637,780
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP2J2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:119,546,458...119,564,843
Ensembl chr 5:119,546,461...119,564,846
|
|
G |
Cyria |
CYFIP related Rac1 interactor A |
increases expression |
ISO |
propionaldehyde results in increased expression of CYRIA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:37,555,167...37,661,196
Ensembl chr 6:37,555,182...37,665,064
|
|
G |
Cysrt1 |
cysteine rich tail 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYSRT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:2,458,295...2,462,037
Ensembl chr 3:2,458,295...2,459,385
|
|
G |
Cyth4 |
cytohesin 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYTH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:119,820,521...119,845,003
Ensembl chr 7:119,820,537...119,845,003
|
|
G |
Cytip |
cytohesin 1 interacting protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CYTIP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:44,150,494...44,225,723
Ensembl chr 3:44,150,992...44,177,689
|
|
G |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DACT3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:78,800,754...78,812,483
Ensembl chr 1:78,800,754...78,812,483
|
|
G |
Dapl1 |
death associated protein-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DAPL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:45,538,408...45,559,281
Ensembl chr 3:45,538,797...45,559,331
|
|
G |
Daw1 |
dynein assembly factor with WD repeats 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DAW1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:88,964,530...89,001,568
Ensembl chr 9:88,964,525...89,001,567
|
|
G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DCBLD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:44,237,814...44,292,884
Ensembl chr11:44,241,111...44,292,884
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DCLK1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:144,646,255...144,939,389
Ensembl chr 2:144,646,308...144,936,927
|
|
G |
Dcst2 |
DC-STAMP domain containing 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DCST2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:188,689,090...188,703,367
Ensembl chr 2:188,688,719...188,704,462
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DDC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774
|
|
G |
Ddo |
D-aspartate oxidase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DDO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:48,739,812...48,758,958
Ensembl chr20:48,739,639...48,758,905
|
|
G |
Defb12 |
defensin beta 12 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEFB105B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:75,118,002...75,120,417
Ensembl chr16:75,118,002...75,120,417
|
|
G |
Defb23 |
defensin beta 23 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEFB129 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:147,928,201...147,932,413
Ensembl chr 3:147,928,201...147,932,413
|
|
G |
Dennd1c |
DENN domain containing 1C |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:9,976,015...9,982,349
Ensembl chr 9:9,970,209...9,982,295
|
|
G |
Dennd2c |
DENN domain containing 2C |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:205,592,348...205,660,619
Ensembl chr 2:205,592,182...205,660,611
|
|
G |
Dennd2d |
DENN domain containing 2D |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND2D mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:209,097,894...209,116,978
Ensembl chr 2:209,097,927...209,116,965
|
|
G |
Depdc1 |
DEP domain containing 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEPDC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:264,704,738...264,738,265
Ensembl chr 2:264,704,769...264,738,257
|
|
G |
Depdc1b |
DEP domain containing 1B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEPDC1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:39,980,796...40,069,982
Ensembl chr 2:40,000,313...40,069,975
|
|
G |
Dgka |
diacylglycerol kinase, alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of DGKA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:3,143,826...3,170,764
Ensembl chr 7:3,143,827...3,170,146
|
|
G |
Dhdh |
dihydrodiol dehydrogenase |
increases expression |
ISO |
propionaldehyde results in increased expression of DHDH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:101,465,937...101,476,867
Ensembl chr 1:101,466,677...101,476,867
|
|
G |
Dhfr |
dihydrofolate reductase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DHFR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHRS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:33,876,701...33,891,559
Ensembl chr15:33,885,106...33,891,539
|
|
G |
Dhrs9 |
dehydrogenase/reductase 9 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHRS9 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 3:55,623,671...55,645,883
Ensembl chr 3:55,623,634...55,648,325
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHX58 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:88,599,722...88,611,562
Ensembl chr10:88,599,680...88,611,105
|
|
G |
Diaph3 |
diaphanous-related formin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DIAPH3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:69,928,507...70,400,077
Ensembl chr15:70,039,424...70,399,924
|
|
G |
Dipk1b |
divergent protein kinase domain 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of DIPK1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:4,083,797...4,091,550
Ensembl chr 3:4,083,864...4,092,289
|
|
G |
Diras1 |
DIRAS family GTPase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DIRAS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:11,556,192...11,561,056
Ensembl chr 7:11,556,192...11,561,056
|
|
G |
Disc1 |
DISC1 scaffold protein |
increases expression |
ISO |
propionaldehyde results in increased expression of DISC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:57,818,838...58,069,992
Ensembl chr19:57,820,260...58,066,152
|
|
G |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DKK3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:176,940,424...176,983,076
Ensembl chr 1:176,940,693...176,983,045
|
|
G |
Dlgap5 |
DLG associated protein 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DLGAP5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:24,167,484...24,199,417
Ensembl chr15:24,167,486...24,199,341
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DLL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:57,318,621...57,326,732
Ensembl chr 1:57,318,708...57,327,379
|
|
G |
Dlx2 |
distal-less homeobox 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DLX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:58,180,088...58,181,971
Ensembl chr 3:58,180,088...58,181,971
|
|
G |
Dmd |
dystrophin |
increases expression |
ISO |
propionaldehyde results in increased expression of DMD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:51,149,358...53,519,271
Ensembl chr X:51,286,737...53,519,259
|
|
G |
Dmkn |
dermokine |
increases expression |
ISO |
propionaldehyde results in increased expression of DMKN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:89,215,266...89,229,696
Ensembl chr 1:89,215,266...89,229,696
|
|
G |
Dnaaf11 |
dynein axonemal assembly factor 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAAF11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:107,130,402...107,231,507
Ensembl chr 7:107,130,402...107,223,047
|
|
G |
Dnaaf2 |
dynein, axonemal, assembly factor 2 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of DNAAF2 gene |
CTD |
PMID:30002397 |
|
NCBI chr 6:91,481,439...91,490,189
Ensembl chr 6:91,481,954...91,490,366
|
|
G |
Dnaaf3 |
dynein, axonemal, assembly factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAAF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:72,874,131...72,882,867
Ensembl chr 1:72,874,404...72,883,002
|
|
G |
Dnah10 |
dynein, axonemal, heavy chain 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:37,237,482...37,365,258
|
|
G |
Dnah12 |
dynein, axonemal, heavy chain 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:2,377,218...2,534,130
Ensembl chr16:2,379,480...2,534,131
|
|
G |
Dnah7 |
dynein, axonemal, heavy chain 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:60,070,087...60,330,121 NCBI chr 9:59,564,253...59,595,347
Ensembl chr 9:60,070,739...60,330,125 Ensembl chr 9:60,070,739...60,330,125
|
|
G |
Dnai1 |
dynein, axonemal, intermediate chain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:57,947,796...58,017,985
Ensembl chr 5:57,947,716...58,017,992
|
|
G |
Dnai3 |
dynein axonemal intermediate chain 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:251,912,432...251,970,699
Ensembl chr 2:251,912,368...251,970,768
|
|
G |
Dnai4 |
dynein axonemal intermediate chain 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:122,551,370...122,642,161
Ensembl chr 5:122,551,405...122,642,202
|
|
G |
Dnai7 |
dynein axonemal intermediate chain 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP94 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:179,440,984...179,476,965
Ensembl chr 4:179,440,953...179,477,070
|
|
G |
Dnajc5b |
DnaJ heat shock protein family (Hsp40) member C5 beta |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAJC5B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:104,290,726...104,382,846
Ensembl chr 2:104,290,726...104,382,878
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression |
ISO |
propionaldehyde results in increased expression of DNER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:91,965,866...92,291,172
Ensembl chr 9:91,965,866...92,291,220
|
|
G |
Dnm3 |
dynamin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:79,906,711...80,379,967
Ensembl chr13:79,910,382...80,379,929
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DOCK4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:60,374,839...60,782,648
Ensembl chr 6:60,566,196...60,782,556
|
|
G |
Dock5 |
dedicator of cytokinesis 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of DOCK5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:44,449,108...44,627,774
Ensembl chr15:44,453,308...44,627,765
|
|
G |
Dpep1 |
dipeptidase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DPEP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:55,973,447...55,998,830
Ensembl chr19:55,982,740...55,998,208
|
|
G |
Dpep3 |
dipeptidase 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DPEP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:37,946,516...37,955,199
Ensembl chr19:37,946,722...37,952,501
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DPP4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:48,291,055...48,372,672
Ensembl chr 3:48,291,055...48,372,672
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
increases expression |
ISO |
propionaldehyde results in increased expression of DPYD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627
|
|
G |
Dpysl5 |
dihydropyrimidinase-like 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of DPYSL5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:26,939,696...27,024,129
Ensembl chr 6:26,939,697...27,024,129
|
|
G |
Drd3 |
dopamine receptor D3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DRD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:61,819,102...61,883,223
Ensembl chr11:61,822,077...61,874,327
|
|
G |
Drgx |
dorsal root ganglia homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DRGX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:8,823,872...8,853,430
Ensembl chr16:8,823,872...8,853,430
|
|
G |
Dscaml1 |
DS cell adhesion molecule-like 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSCAML1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:49,733,835...50,056,115
Ensembl chr 8:49,737,798...50,055,560
|
|
G |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSCC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:94,759,076...94,774,787
Ensembl chr 7:94,758,800...94,774,569
|
|
G |
Dsn1 |
DSN1 component of MIS12 kinetochore complex |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:153,101,020...153,115,326
Ensembl chr 3:153,101,036...153,114,520
|
|
G |
Dtx1 |
deltex E3 ubiquitin ligase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DTX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:41,383,885...41,415,783
Ensembl chr12:41,385,241...41,414,754
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
|
|
G |
Dusp26 |
dual specificity phosphatase 26 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP26 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:64,798,782...64,806,459
Ensembl chr16:64,798,778...64,806,050
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
|
|
G |
Dydc2 |
DPY30 domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DYDC2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:18,635,235...18,649,074
Ensembl chr16:18,635,388...18,645,941
|
|
G |
E2f7 |
E2F transcription factor 7 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of E2F7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:53,275,659...53,318,261
Ensembl chr 7:53,275,676...53,316,481
|
|
G |
E2f8 |
E2F transcription factor 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of E2F8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:104,185,436...104,203,683
Ensembl chr 1:104,187,100...104,202,591
|
|
G |
Ebi3 |
Epstein-Barr virus induced 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EBI3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:11,110,874...11,114,843
Ensembl chr 9:11,110,874...11,114,843
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ECM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:197,855,468...197,860,973
Ensembl chr 2:197,855,460...197,860,699
|
|
G |
Edn2 |
endothelin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EDN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:139,098,472...139,106,396
Ensembl chr 5:139,100,898...139,105,792
|
|
G |
Edn3 |
endothelin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EDN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:172,856,730...172,879,276
Ensembl chr 3:172,856,733...172,880,450
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EEF1A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:176,657,104...176,666,282
Ensembl chr 3:176,657,107...176,666,282
|
|
G |
Efcab10 |
EF-hand calcium binding domain 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFCAB10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:52,702,304...52,709,223
Ensembl chr 6:52,702,544...52,709,223
|
|
G |
Efcab11 |
EF-hand calcium binding domain 11 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EFCAB11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:123,742,971...123,894,714
Ensembl chr 6:123,743,064...123,894,826
|
|
G |
Efcab2 |
EF-hand calcium binding domain 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EFCAB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:96,303,578...96,414,404
Ensembl chr13:96,303,703...96,414,404
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFEMP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:113,202,382...113,294,993
Ensembl chr14:113,202,419...113,295,014
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFHD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:94,362,249...94,408,884
Ensembl chr 9:94,362,299...94,408,885
|
|
G |
Efnb2 |
ephrin B2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFNB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:86,631,151...86,672,050
Ensembl chr16:86,631,064...86,675,049
|
|
G |
Efnb3 |
ephrin B3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFNB3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:56,161,431...56,168,819
Ensembl chr10:56,161,432...56,167,426
|
|
G |
Efr3b |
EFR3 homolog B |
increases expression |
ISO |
propionaldehyde results in increased expression of EFR3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:28,390,541...28,464,174
Ensembl chr 6:28,393,016...28,464,118
|
|
G |
Egr2 |
early growth response 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EGR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
|
|
G |
Elapor1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELAPOR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:211,243,398...211,323,283
Ensembl chr 2:211,246,068...211,322,719
|
|
G |
Elfn2 |
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELFN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:119,889,786...119,897,038
Ensembl chr 7:119,894,066...119,896,925
|
|
G |
Elmod1 |
ELMO domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELMOD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:58,486,078...58,542,884
Ensembl chr 8:58,486,078...58,542,844
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELOVL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:265,883,353...265,887,181
Ensembl chr 1:265,883,355...265,887,226
|
|
G |
Elovl4 |
ELOVL fatty acid elongase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELOVL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:91,310,690...91,338,625
Ensembl chr 8:91,310,630...91,338,843
|
|
G |
Eme1 |
essential meiotic structure-specific endonuclease 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EME1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:82,366,820...82,375,510
Ensembl chr10:82,367,084...82,374,171
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EMP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:169,161,076...169,181,967
Ensembl chr 4:169,147,243...169,181,966
|
|
G |
Enho |
energy homeostasis associated |
increases expression |
ISO |
propionaldehyde results in increased expression of ENHO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:58,018,039...58,019,836
Ensembl chr 5:58,018,039...58,019,836
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
|
|
G |
Eno3 |
enolase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENO3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:57,278,271...57,283,661
Ensembl chr10:57,278,307...57,283,653
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENOX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:59,331,134...59,884,512
Ensembl chr15:59,678,165...59,884,511
|
|
G |
Eomes |
eomesodermin |
increases expression |
ISO |
propionaldehyde results in increased expression of EOMES mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:127,144,367...127,152,618
Ensembl chr 8:127,144,903...127,151,493
|
|
G |
Epc2 |
enhancer of polycomb homolog 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EPC2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:33,641,616...33,741,219
Ensembl chr 3:33,641,616...33,740,461
|
|
G |
Epha10 |
EPH receptor A10 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHA10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:142,875,171...142,910,537
Ensembl chr 5:142,875,773...142,908,395
|
|
G |
Epha2 |
Eph receptor A2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:159,845,773...159,874,203
Ensembl chr 5:159,845,774...159,874,206
|
|
G |
Ephb2 |
Eph receptor B2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:155,024,478...155,143,539
Ensembl chr 5:155,022,493...155,204,456
|
|
G |
Ephb3 |
Eph receptor B3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHB3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:83,527,960...83,546,742
Ensembl chr11:83,527,962...83,546,674
|
|
G |
Epn3 |
epsin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:82,220,762...82,231,200
Ensembl chr10:82,220,762...82,229,140
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
propionaldehyde results in increased expression of EREG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:18,577,620...18,591,395
Ensembl chr14:18,576,355...18,591,394
|
|
G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ERGIC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:16,821,393...16,912,050
Ensembl chr10:16,821,880...16,910,641
|
|
G |
Erich4 |
glutamate-rich 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERICH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:82,407,899...82,409,639
Ensembl chr 1:82,407,899...82,409,639
|
|
G |
Ermap |
erythroblast membrane associated protein (Scianna blood group) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERMAP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:138,227,168...138,240,509
Ensembl chr 5:138,227,855...138,239,306
|
|
G |
Erp27 |
endoplasmic reticulum protein 27 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERP27 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:170,893,946...170,912,629
Ensembl chr 4:170,893,946...170,912,629
|
|
G |
Esam |
endothelial cell adhesion molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of ESAM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:39,997,875...40,008,802
Ensembl chr 8:39,997,875...40,008,809
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ESCO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:42,500,929...42,519,019
Ensembl chr15:42,500,929...42,518,855
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ESPL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:143,896,890...143,923,868
Ensembl chr 7:143,897,014...143,923,868
|
|
G |
Etnk2 |
ethanolamine kinase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ETNK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:50,481,178...50,498,991
Ensembl chr13:50,481,163...50,499,140
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ETS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:36,075,709...36,092,495
Ensembl chr11:36,075,709...36,092,495
|
|
G |
Evi5l |
ecotropic viral integration site 5-like |
increases expression |
ISO |
propionaldehyde results in increased expression of EVI5L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:2,588,066...2,626,336
Ensembl chr12:2,587,891...2,626,310
|
|
G |
Exoc3l4 |
exocyst complex component 3-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of EXOC3L4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:135,866,132...135,880,724
Ensembl chr 6:135,866,739...135,880,721
|
|
G |
Exosc8 |
exosome component 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EXOSC8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:143,925,643...143,932,240
Ensembl chr 2:143,925,546...143,931,940
|
|
G |
Exph5 |
exophilin 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of EXPH5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:57,885,932...57,962,574
Ensembl chr 8:57,886,168...57,962,708
|
|
G |
F13b |
coagulation factor XIII B chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F13B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:56,598,891...56,623,132
Ensembl chr13:56,598,957...56,623,124
|
|
G |
F2 |
coagulation factor II |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:80,529,468...80,542,993
Ensembl chr 3:80,529,428...80,543,031
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of F2R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340
|
|
G |
F5 |
coagulation factor V |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:82,479,997...82,535,540
Ensembl chr13:82,479,998...82,535,534
|
|
G |
F7 |
coagulation factor VII |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:81,824,610...81,834,923
Ensembl chr16:81,824,111...81,834,945
|
|
G |
Fa2h |
fatty acid 2-hydroxylase |
increases expression |
ISO |
propionaldehyde results in increased expression of FA2H mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:43,545,380...43,596,788
Ensembl chr19:43,545,378...43,596,801
|
|
G |
Faap24 |
FA core complex associated protein 24 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAAP24 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:91,657,263...91,663,485
Ensembl chr 1:91,657,263...91,663,467
|
|
G |
Fabp6 |
fatty acid binding protein 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of FABP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:29,191,621...29,196,593
Ensembl chr10:29,191,623...29,196,563
|
|
G |
Fam110a |
family with sequence similarity 110, member A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAM110A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:147,476,580...147,487,170
Ensembl chr 3:147,476,580...147,487,170
|
|
G |
Fam126a |
family with sequence similarity 126, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM126A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:7,661,710...7,770,179
Ensembl chr 4:7,661,558...7,770,232
|
|
G |
Fam133a |
family with sequence similarity 133, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM133A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:95,062,119...95,235,281
|
|
G |
Fam13a |
family with sequence similarity 13, member A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAM13A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:89,183,180...89,281,282
Ensembl chr 4:89,183,768...89,281,222
|
|
G |
Fam184a |
family with sequence similarity 184, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM184A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:34,935,029...35,054,806
Ensembl chr20:34,936,050...35,054,881
|
|
G |
Fam189a2 |
family with sequence similarity 189, member A2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM189A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:241,822,152...241,876,089
Ensembl chr 1:241,822,626...241,875,864
|
|
G |
Fam25a |
family with sequence similarity 25, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM25A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:10,702,264...10,706,073
Ensembl chr16:10,702,263...10,706,073
|
|
G |
Fam43a |
family with sequence similarity 43, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM43A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:73,676,601...73,679,003
Ensembl chr11:73,676,601...73,678,984
|
|
G |
Fam43b |
family with sequence similarity 43, member B |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM43B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:156,809,705...156,813,352
Ensembl chr 5:156,810,658...156,811,650
|
|
G |
Fam71f1 |
family with sequence similarity 71, member F1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM71F1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:56,591,719...56,615,157
Ensembl chr 4:56,591,715...56,615,158
|
|
G |
Fam90a1 |
family with sequence similarity 90, member A1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM90A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:75,001,033...75,016,173
|
|
G |
Fancd2 |
FA complementation group D2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FANCD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:145,489,869...145,551,479
Ensembl chr 4:145,489,869...145,551,479
|
|
G |
Fanci |
FA complementation group I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FANCI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:141,116,565...141,172,997
Ensembl chr 1:141,120,166...141,172,483
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of FAS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Faslg |
Fas ligand |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FASLG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fblim1 |
filamin binding LIM protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLIM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:160,122,466...160,158,921
Ensembl chr 5:160,122,425...160,158,386
|
|
G |
Fbln2 |
fibulin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:122,835,237...122,895,127
Ensembl chr 4:122,835,436...122,895,121
|
|
G |
Fbln5 |
fibulin 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLN5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:125,644,797...125,723,957
Ensembl chr 6:125,644,804...125,723,944
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:53,068,495...53,272,254
Ensembl chr18:53,068,495...53,181,503
|
|
G |
Fbxo2 |
F-box protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBXO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:164,972,483...164,977,912
Ensembl chr 5:164,972,480...164,977,916
|
|
G |
Fbxo24 |
F-box protein 24 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO24 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:22,138,460...22,153,670
Ensembl chr12:22,142,520...22,152,871
|
|
G |
Fbxo41 |
F-box protein 41 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBXO41 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:117,255,143...117,285,228
Ensembl chr 4:117,256,770...117,268,178
|
|
G |
Fbxo43 |
F-box protein 43 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO43 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:74,925,091...74,938,796
Ensembl chr 7:74,925,092...74,938,663
|
|
G |
Fbxo5 |
F-box protein 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:42,461,277...42,467,646
Ensembl chr 1:42,461,291...42,467,586
|
|
G |
Fbxw12 |
F-box and WD repeat domain containing 12 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXW12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:117,871,409...117,890,944
Ensembl chr 8:117,871,442...117,890,930
|
|
G |
Fcrl2 |
Fc receptor-like 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FCRL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:186,594,442...186,605,115
Ensembl chr 2:186,595,051...186,606,172
|
|
G |
Fdxr |
ferredoxin reductase |
increases expression |
ISO |
propionaldehyde results in increased expression of FDXR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:103,817,724...103,826,413
Ensembl chr10:103,817,704...103,826,448
|
|
G |
Fer1l6 |
fer-1-like family member 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FER1L6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:98,399,207...98,555,215
Ensembl chr 7:98,432,024...98,553,096
|
|
G |
Fez1 |
fasciculation and elongation protein zeta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FEZ1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:39,305,128...39,350,270
Ensembl chr 8:39,305,128...39,350,270
|
|
G |
Ffar2 |
free fatty acid receptor 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FFAR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:89,268,197...89,271,942
Ensembl chr 1:89,268,938...89,269,930
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:182,028,044...182,035,026
Ensembl chr 2:182,027,115...182,038,178
|
|
G |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:15,737,962...15,800,403
Ensembl chr17:15,749,978...15,800,401
|
|
G |
Fgf13 |
fibroblast growth factor 13 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGF13 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:142,053,648...142,589,274
Ensembl chr X:142,053,654...142,248,369
|
|
G |
Fgf20 |
fibroblast growth factor 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGF20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:55,152,748...55,159,352
Ensembl chr16:55,152,748...55,159,352
|
|
G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGFBP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:71,647,429...71,650,359
Ensembl chr14:71,649,274...71,650,354
|
|
G |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGFBP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:255,555,050...255,557,055
Ensembl chr 1:255,555,050...255,557,055
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
|
|
G |
Fgl1 |
fibrinogen-like 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:54,153,086...54,188,120
Ensembl chr16:54,153,054...54,188,181
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FHL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:49,920,611...49,994,906
Ensembl chr 9:49,920,854...49,950,093
|
|
G |
Fhod3 |
formin homology 2 domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FHOD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:16,650,786...17,332,209
Ensembl chr18:16,650,806...17,332,210
|
|
G |
Fignl1 |
fidgetin-like 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FIGNL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:91,895,902...91,904,474
Ensembl chr14:91,895,909...91,904,433
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of FKBP1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:29,975,863...29,987,252
Ensembl chr 6:29,977,797...29,987,451
|
|
G |
Flcn |
folliculin |
increases expression |
ISO |
propionaldehyde results in increased expression of FLCN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:46,153,185...46,172,331
Ensembl chr10:46,153,188...46,172,309
|
|
G |
Flna |
filamin A |
increases expression |
ISO |
propionaldehyde results in increased expression of FLNA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:156,460,785...156,487,245
Ensembl chr X:156,463,953...156,487,245
|
|
G |
Flywch1 |
FLYWCH-type zinc finger 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FLYWCH1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:13,087,925...13,107,833
Ensembl chr10:13,087,914...13,107,771
|
|
G |
Fmo4 |
flavin containing dimethylaniline monoxygenase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FMO4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:80,685,385...80,703,575
Ensembl chr13:80,685,325...80,703,615
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FMO5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:199,796,870...199,823,927
Ensembl chr 2:199,796,881...199,823,927
|
|
G |
Fmod |
fibromodulin |
increases expression |
ISO |
propionaldehyde results in increased expression of FMOD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:50,874,886...50,885,503
Ensembl chr13:50,873,605...50,885,563
|
|
G |
Fn3k |
fructosamine 3 kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FN3K mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:110,626,462...110,642,262
Ensembl chr10:110,631,494...110,642,260
|
|
G |
Fndc11 |
fibronectin type III domain containing 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:176,721,100...176,724,736
Ensembl chr 3:176,721,827...176,725,837
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:113,109,949...113,415,171
Ensembl chr 2:113,112,902...113,345,577
|
|
G |
Fndc5 |
fibronectin type III domain containing 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:147,323,240...147,330,266
Ensembl chr 5:147,323,240...147,330,266
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FOS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FOXM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:161,685,236...161,697,633
Ensembl chr 4:161,685,258...161,696,305
|
|
G |
Foxn4 |
forkhead box N4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FOXN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:48,101,012...48,121,281
Ensembl chr12:48,101,673...48,121,270
|
|
G |
Fpr1 |
formyl peptide receptor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FPR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:59,759,025...59,767,258
Ensembl chr 1:59,765,835...59,767,042
|
|
G |
Frat1 |
FRAT regulator of WNT signaling pathway 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRAT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:261,071,965...261,075,244
|
|
G |
Frg2 |
FSHD region gene 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:85,779,927...85,792,527
Ensembl chr14:85,791,159...85,792,257
|
|
G |
Frmd4b |
FERM domain containing 4B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRMD4B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:129,658,137...129,984,735
Ensembl chr 4:129,658,840...129,846,642
|
|
G |
Frmd5 |
FERM domain containing 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRMD5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:113,480,780...113,755,286
Ensembl chr 3:113,483,269...113,525,864
|
|
G |
Frmd8 |
FERM domain containing 8 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRMD8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:221,213,312...221,233,967
Ensembl chr 1:221,213,312...221,233,962
|
|
G |
Frrs1 |
ferric-chelate reductase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRRS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:220,415,568...220,469,559
Ensembl chr 2:220,432,037...220,468,859
|
|
G |
Fry |
FRY microtubule binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRY mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:5,573,729...5,822,874
Ensembl chr12:5,573,729...5,822,874
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
ISO |
propionaldehyde results in increased expression of FRZB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:67,635,604...67,668,772
Ensembl chr 3:67,635,607...67,668,772
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSCN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:13,655,459...13,668,595
Ensembl chr12:13,656,554...13,668,515
|
|
G |
Fstl3 |
follistatin like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSTL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:12,806,031...12,810,556
Ensembl chr 7:12,804,919...12,810,570
|
|
G |
Fstl4 |
follistatin-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSTL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:38,104,344...38,532,216
Ensembl chr10:38,104,558...38,532,196
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
increases expression |
ISO |
propionaldehyde results in increased expression of FTCD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:12,806,957...12,820,466
Ensembl chr20:12,806,957...12,820,466
|
|
G |
Fuom |
fucose mutarotase |
increases expression |
ISO |
propionaldehyde results in increased expression of FUOM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:212,563,714...212,568,224
Ensembl chr 1:212,563,714...212,568,224
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FXYD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:49,710,334...49,717,492
Ensembl chr 8:49,710,477...49,716,955
|
|
G |
Fxyd7 |
FXYD domain-containing ion transport regulator 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of FXYD7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:89,474,601...89,484,069
Ensembl chr 1:89,474,601...89,483,988
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
propionaldehyde results in increased expression of FYN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GABBR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:62,276,100...62,621,737
Ensembl chr 5:62,276,100...62,621,737
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GAD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:56,861,440...56,902,139
Ensembl chr 3:56,861,396...56,902,157
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of GADD45A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
propionaldehyde results in increased expression of GADD45G mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:13,391,474...13,393,219
Ensembl chr17:13,391,467...13,393,243
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases expression |
ISO |
propionaldehyde results in increased expression of GAL mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:218,653,059...218,657,922
Ensembl chr 1:218,652,917...218,657,925
|
|
G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GAL3ST1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:84,231,473...84,247,371
Ensembl chr14:84,231,639...84,247,369
|
|
G |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:43,067,316...43,208,992
Ensembl chr10:43,067,299...43,210,427
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT16 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:104,069,853...104,250,177
Ensembl chr 6:104,068,547...104,250,174
|
|
G |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:176,296,186...176,607,466
Ensembl chr 1:176,296,193...176,607,466
|
|
G |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:44,025,964...44,072,073
Ensembl chr 3:44,025,300...44,074,678
|
|
G |
Galnt6 |
polypeptide N-acetylgalactosaminyltransferase 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:142,322,172...142,364,281
Ensembl chr 7:142,322,172...142,352,382
|
|
G |
Galntl6 |
polypeptide N-acetylgalactosaminyltransferase-like 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GALNTL6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:34,551,052...35,803,840
Ensembl chr16:35,573,058...35,802,979
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of GAMT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:12,314,848...12,317,998
Ensembl chr 7:12,314,848...12,317,998
|
|
G |
Garnl3 |
GTPase activating Rap/RanGAP domain-like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GARNL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:12,034,131...12,176,591
Ensembl chr 3:12,034,413...12,155,098
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GAS2L3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:29,963,129...29,996,021
Ensembl chr 7:29,959,597...29,986,163
|
|
G |
Gata5 |
GATA binding protein 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GATA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:175,701,278...175,709,465
Ensembl chr 3:175,701,280...175,709,465
|
|
G |
Gba3 |
glucosylceramidase beta 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GBA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:64,390,793...64,535,213
Ensembl chr14:64,390,793...64,535,170
|
|
G |
Gbp1 |
guanylate binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GBP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:248,343,334...248,423,402
Ensembl chr 2:248,398,917...248,409,570
|
|
G |
Gbx2 |
gastrulation brain homeobox 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GBX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:97,063,265...97,065,855
Ensembl chr 9:97,063,728...97,065,817
|
|
G |
Gcgr |
glucagon receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of GCGR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:109,707,863...109,716,253
Ensembl chr10:109,707,962...109,716,128
|
|
G |
Gckr |
glucokinase regulator |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GCKR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:26,355,296...26,385,761
Ensembl chr 6:26,355,296...26,385,761
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GCLC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GCNT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:236,547,729...236,585,037
Ensembl chr 1:236,580,034...236,585,035
|
|
G |
Gdf11 |
growth differentiation factor 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDF11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:3,306,863...3,315,856
Ensembl chr 7:3,306,863...3,315,856
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDF15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
|
|
G |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDPD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:74,334,972...74,376,332
Ensembl chr10:74,334,975...74,376,270
|
|
G |
Gfi1 |
growth factor independent 1 transcriptional repressor |
increases expression |
ISO |
propionaldehyde results in increased expression of GFI1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:3,058,035...3,073,332
Ensembl chr14:3,058,993...3,068,371
|
|
G |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GFOD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:23,818,370...23,924,393
Ensembl chr17:23,823,632...23,923,792
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GFRA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:279,203,046...279,572,789
|
|
G |
Gfra4 |
GDNF family receptor alpha 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GFRA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:123,573,394...123,582,431
Ensembl chr 3:123,578,997...123,581,518
|
|
G |
Gins1 |
GINS complex subunit 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GINS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:146,695,366...146,716,787
Ensembl chr 3:146,695,344...146,716,816
|
|
G |
Gins2 |
GINS complex subunit 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GINS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:54,151,048...54,163,701
Ensembl chr19:54,151,048...54,163,608
|
|
G |
Gja3 |
gap junction protein, alpha 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:37,298,607...37,325,370
Ensembl chr15:37,299,738...37,325,178
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GJB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:71,272,030...71,279,973
Ensembl chr X:71,272,042...71,279,977
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:37,377,313...37,394,494
Ensembl chr15:37,377,316...37,383,277
|
|
G |
Gjb4 |
gap junction protein, beta 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:145,416,343...145,421,122
Ensembl chr 5:145,416,343...145,418,992
|
|
G |
Gjb5 |
gap junction protein, beta 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:145,422,034...145,440,558
Ensembl chr 5:145,422,357...145,423,172
|
|
G |
Gjd3 |
gap junction protein, delta 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:86,888,982...86,891,915
Ensembl chr10:86,889,421...86,890,257
|
|
G |
Gkn1 |
gastrokine 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GKN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,143,070...119,148,358
Ensembl chr 4:119,143,070...119,148,358
|
|
G |
Gkn2 |
gastrokine 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GKN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,131,255...119,177,329
Ensembl chr 4:119,171,245...119,177,329
|
|
G |
Gldc |
glycine decarboxylase |
increases expression |
ISO |
propionaldehyde results in increased expression of GLDC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:248,295,140...248,377,122
Ensembl chr 1:248,297,331...248,377,093
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GLIPR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:54,767,828...54,778,823
Ensembl chr 7:54,767,827...54,778,848
|
|
G |
Glipr2 |
GLI pathogenesis-related 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GLIPR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:59,415,415...59,446,732
Ensembl chr 5:59,416,076...59,446,647
|
|
G |
Glyctk |
glycerate kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GLYCTK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:114,846,210...114,853,374
Ensembl chr 8:114,848,084...114,853,103
|
|
G |
Gm2a |
GM2 ganglioside activator |
increases expression |
ISO |
propionaldehyde results in increased expression of GM2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:40,438,394...40,450,927
Ensembl chr10:40,438,356...40,450,930
|
|
G |
Gmpr |
guanosine monophosphate reductase |
increases expression |
ISO |
propionaldehyde results in increased expression of GMPR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:19,543,274...19,580,929
Ensembl chr17:19,543,275...19,580,929
|
|
G |
Gnao1 |
G protein subunit alpha o1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GNAO1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:11,513,201...11,669,578
Ensembl chr19:11,513,201...11,669,578
|
|
G |
Gnaz |
G protein subunit alpha z |
increases expression |
ISO |
propionaldehyde results in increased expression of GNAZ mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:14,593,072...14,644,020
Ensembl chr20:14,593,819...14,620,019
|
|
G |
Gng7 |
G protein subunit gamma 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of GNG7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:11,565,740...11,629,519
Ensembl chr 7:11,582,984...11,628,929
|
|
G |
Golga7b |
golgin A7 family, member B |
increases expression |
ISO |
propionaldehyde results in increased expression of GOLGA7B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:261,494,511...261,514,413
Ensembl chr 1:261,497,059...261,516,892
|
|
G |
Gpr143 |
G protein-coupled receptor 143 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR143 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:23,668,363...23,693,162
Ensembl chr X:23,668,363...23,693,162
|
|
G |
Gpr146 |
G protein-coupled receptor 146 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPR146 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:17,343,396...17,358,631
Ensembl chr12:17,345,510...17,358,617
|
|
G |
Gpr155 |
G protein-coupled receptor 155 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR155 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:60,051,545...60,105,567
Ensembl chr 3:60,051,535...60,105,242
|
|
G |
Gpr160 |
G protein-coupled receptor 160 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR160 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:116,105,110...116,162,036
Ensembl chr 2:116,105,111...116,161,998
|
|
G |
Gpr173 |
G-protein coupled receptor 173 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPR173 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:22,417,753...22,418,873
Ensembl chr X:22,417,753...22,418,873
|
|
G |
Gpr20 |
G protein-coupled receptor 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:114,943,675...114,953,977
Ensembl chr 7:114,944,282...114,945,344
|
|
G |
Gpr37l1 |
G protein-coupled receptor 37-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR37L1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:51,985,698...51,992,547
Ensembl chr13:51,985,684...51,992,693
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR87 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:149,398,949...149,418,041
Ensembl chr 2:149,398,949...149,417,212
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of GPRC5A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:168,832,937...168,851,650
Ensembl chr 4:168,832,910...168,851,652
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:99,839,960...99,843,245
Ensembl chr 6:99,839,960...99,843,245
|
|
G |
Gramd1c |
GRAM domain containing 1C |
increases expression |
ISO |
propionaldehyde results in increased expression of GRAMD1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:61,609,370...61,659,355 NCBI chr11:62,580,983...62,634,961
Ensembl chr11:61,605,937...62,634,803
|
|
G |
Gramd2b |
GRAM domain containing 2B |
increases expression |
ISO |
propionaldehyde results in increased expression of GRAMD2B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:51,492,196...51,591,028
Ensembl chr18:51,492,196...51,591,026
|
|
G |
Greb1l |
GREB1 like retinoic acid receptor coactivator |
increases expression |
ISO |
propionaldehyde results in increased expression of GREB1L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:1,537,315...1,784,260
Ensembl chr18:1,723,565...1,784,233
|
|
G |
Grhl1 |
grainyhead-like transcription factor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRHL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:43,734,837...43,795,757
Ensembl chr 6:43,743,702...43,794,342
|
|
G |
Grhl3 |
grainyhead-like transcription factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRHL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:153,893,039...153,925,045
Ensembl chr 5:153,893,039...153,924,896
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
ISO |
propionaldehyde results in increased expression of GRIN2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:103,798,290...103,816,923
Ensembl chr10:103,798,291...103,816,287
|
|
G |
Grin3b |
glutamate ionotropic receptor NMDA type subunit 3B |
increases expression |
ISO |
propionaldehyde results in increased expression of GRIN3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:12,764,993...12,771,310
Ensembl chr 7:12,764,993...12,771,310
|
|
G |
Grm4 |
glutamate metabotropic receptor 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRM4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:6,745,682...6,791,521
Ensembl chr20:6,745,682...6,791,519
|
|
G |
Grp |
gastrin releasing peptide |
increases expression |
ISO |
propionaldehyde results in increased expression of GRP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:61,563,458...61,576,818
Ensembl chr18:61,563,053...61,576,818
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GSTA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GSTM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:210,685,204...210,688,273
Ensembl chr 2:210,685,197...210,688,272
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GSTM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272
|
|
G |
Gsto2 |
glutathione S-transferase omega 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GSTO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:267,617,517...267,640,455
Ensembl chr 1:271,229,036...271,243,517 Ensembl chr 1:271,229,036...271,243,517
|
|
G |
Gtf2ird2 |
GTF2I repeat domain containing 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GTF2IRD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:25,509,059...25,555,554
Ensembl chr12:25,509,653...25,546,200
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GTSE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:126,736,416...126,753,221
Ensembl chr 7:126,736,732...126,753,220
|
|
G |
Guca2a |
guanylate cyclase activator 2A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GUCA2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:138,685,634...138,687,476
Ensembl chr 5:138,685,624...138,687,816
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GUCY1B1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:180,976,939...181,026,001
Ensembl chr 2:180,976,939...181,026,024
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H1-4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:43,734,461...43,735,120
Ensembl chr17:43,734,461...43,735,120
|
|
G |
H1f8 |
H1.8 linker histone |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H1-8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:147,844,658...147,849,779
Ensembl chr 4:147,844,658...147,849,779
|
|
G |
H2ac1 |
H2A clustered histone 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:43,422,454...43,422,846
Ensembl chr17:43,422,454...43,422,846
|
|
G |
H2ac20 |
H2A clustered histone 20 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:198,360,271...198,360,735
Ensembl chr 2:198,360,301...198,360,678
|
|
G |
H2ac21 |
H2A clustered histone 21 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:198,359,754...198,360,146
Ensembl chr 2:198,359,754...198,360,146
|
|
G |
Habp2 |
hyaluronan binding protein 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HABP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:277,068,715...277,104,567
Ensembl chr 1:277,068,761...277,104,566
|
|
G |
Hao1 |
hydroxyacid oxidase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HAO1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:127,444,900...127,500,709
Ensembl chr 3:127,444,902...127,500,709
|
|
G |
Hapln3 |
hyaluronan and proteoglycan link protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of HAPLN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:140,827,279...140,845,386
Ensembl chr 1:140,827,295...140,835,151
|
|
G |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HAPLN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:21,081,377...21,089,508
Ensembl chr16:21,081,377...21,089,508
|
|
G |
Has3 |
hyaluronan synthase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of HAS3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:39,063,298...39,077,745
Ensembl chr19:39,063,998...39,077,722
|
|
G |
Haspin |
histone H3 associated protein kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HASPIN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:59,695,403...59,698,398
Ensembl chr10:59,695,913...59,698,168
|
|
G |
Hbe1 |
hemoglobin subunit epsilon 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HBE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:169,003,904...169,005,184
Ensembl chr 1:169,003,788...169,005,190
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
ISO |
propionaldehyde results in increased expression of HBEGF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:29,330,302...29,340,185
Ensembl chr18:29,329,764...29,340,403
|
|
G |
Hbg1 |
hemoglobin subunit gamma 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HBG1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:168,992,841...168,994,219
Ensembl chr 1:168,992,722...168,994,253
|
|
G |
Hbq1b |
hemoglobin subunit theta 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of HBQ1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:15,599,821...15,602,680
Ensembl chr10:15,600,220...15,600,858
|
|
G |
Hcn4 |
hyperpolarization activated cyclic nucleotide-gated potassium channel 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of HCN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:63,599,907...63,637,327
Ensembl chr 8:63,600,663...63,639,654
|
|
G |
Hcst |
hematopoietic cell signal transducer |
increases expression |
ISO |
propionaldehyde results in increased expression of HCST mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:88,879,425...88,881,653
Ensembl chr 1:88,879,428...88,881,460
|
|
G |
Hdac7 |
histone deacetylase 7 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HDAC7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:139,280,396...139,319,108
Ensembl chr 7:139,281,187...139,318,455
|
|
G |
Hes2 |
hes family bHLH transcription factor 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of HES2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:169,338,097...169,339,142
Ensembl chr 5:169,338,097...169,339,142
|
|
G |
Hes7 |
hes family bHLH transcription factor 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of HES7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:55,704,485...55,710,523
Ensembl chr10:55,707,164...55,709,687
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HEY1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:95,320,147...95,322,701
Ensembl chr 2:95,320,283...95,322,696
|
|
G |
Hfe |
homeostatic iron regulator |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HFE mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:43,661,276...43,669,327
Ensembl chr17:43,661,222...43,669,985
|
|
G |
Hgd |
homogentisate 1, 2-dioxygenase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HGD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:65,983,221...66,034,555
Ensembl chr11:65,983,221...66,034,573
|
|
G |
Hhipl2 |
HHIP like 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HHIPL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:101,814,574...101,835,144
Ensembl chr13:101,814,574...101,834,584
|
|
G |
Hic1 |
HIC ZBTB transcriptional repressor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HIC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:62,007,150...62,010,774
Ensembl chr10:62,007,150...62,009,582
|
|
G |
Hid1 |
HID1 domain containing |
increases expression |
ISO |
propionaldehyde results in increased expression of HID1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:103,899,160...103,919,649
Ensembl chr10:103,899,150...103,919,605
|
|
G |
Hils1 |
histone linker H1 domain, spermatid-specific 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H1-9P mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:82,775,691...82,776,487
Ensembl chr10:82,775,691...82,776,487
|
|
G |
Hirip3 |
HIRA interacting protein 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HIRIP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:198,298,138...198,301,164
Ensembl chr 1:198,298,138...198,301,161
|
|
G |
Hist1h2ak |
histone cluster 1, H2ak |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:44,840,990...44,841,382
Ensembl chr17:44,840,990...44,841,382
|
|
G |
Hist1h3b |
histone cluster 1, H3b |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H3C12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:44,760,023...44,764,058
Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131 Ensembl chr17:44,839,721...44,840,131
|
|
G |
Hist1h4b |
histone cluster 1 H4 family member B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C9 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:44,522,144...44,526,587
Ensembl chr17:44,522,140...44,526,583
|
|
G |
Hist1h4m |
histone cluster 1, H4m |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C1 mRNA |
CTD |
PMID:26079696 |
|
Ensembl chr17:44,815,684...44,815,995
|
|
G |
Hist2h4 |
histone cluster 2, H4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:198,411,955...198,412,350
Ensembl chr 2:198,411,955...198,412,350
|
|
G |
Hist2h4a |
histone cluster 2 H4 family member A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:170,800,539...170,800,979
Ensembl chr17:43,770,250...43,770,561 Ensembl chr17:43,770,250...43,770,561 Ensembl chr17:43,770,250...43,770,561 Ensembl chr17:43,770,250...43,770,561 Ensembl chr 2:43,770,250...43,770,561 Ensembl chr17:43,770,250...43,770,561 Ensembl chr17:43,770,250...43,770,561 Ensembl chr17:43,770,250...43,770,561 Ensembl chr 4:43,770,250...43,770,561 Ensembl chr 4:43,770,250...43,770,561 Ensembl chr 4:43,770,250...43,770,561 Ensembl chr 4:43,770,250...43,770,561
|
|
G |
Hivep3 |
HIVEP zinc finger 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of HIVEP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:138,774,501...139,077,403
Ensembl chr 5:139,007,642...139,077,377
|
|
G |
Hjurp |
Holliday junction recognition protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HJURP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:95,347,739...95,362,228
Ensembl chr 9:95,349,086...95,362,014
|
|
G |
Hk2 |
hexokinase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of HK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:113,559,396...113,609,897
Ensembl chr 4:113,559,427...113,610,243
|
|
G |
Hkdc1 |
hexokinase domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HKDC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:32,018,027...32,054,494
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HMGB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:36,077,615...36,080,191
Ensembl chr16:36,077,617...36,080,191 Ensembl chr11:36,077,617...36,080,191
|
|
G |
Hmgb3 |
high mobility group box 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HMGB3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:36,690,190...36,694,329
Ensembl chr17:36,690,249...36,694,325 Ensembl chr14:36,690,249...36,694,325
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HMGCS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
|
|
G |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HMGN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:152,195,359...152,198,813
Ensembl chr 5:152,195,361...152,198,813
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HMMR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:25,861,490...25,890,639
Ensembl chr10:25,861,490...25,890,639
|
|
G |
Hmx1 |
H6 family homeobox 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HMX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:80,540,558...80,544,607
Ensembl chr14:80,541,075...80,544,342
|
|
G |
Hnf1a |
HNF1 homeobox A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HNF1A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:47,407,811...47,433,342
Ensembl chr12:47,407,811...47,433,342
| |